Abstract
This thesis discusses the elimination of disease and burden of disease. In the first part, this thesis outlines the cost-effectiveness of several strategies contribution to hepatitis C elimination. In the second part, this thesis assess if antiviral resistance proposes a barrier towards the hepatitis C elimination goals. The final part focusses on HIV, a chronic disease, where the disease burden plays an important role
| Original language | English |
|---|---|
| Awarding Institution |
|
| Supervisors/Advisors |
|
| Award date | 2 Jun 2021 |
| Place of Publication | Rotterdam |
| Print ISBNs | 978-94-6416-362-9 |
| Publication status | Published - 2 Jun 2021 |
Bibliographical note
The research described in this thesis was supported by an unrestricted educational grant from Gilead Sciences [NL-2018-000171] and the NoCo grant [IN-NL-987-4558] and additional research grants from MSD (SDD 343462), Gilead (215001269)], ViiV Healthcare (14-0614-ViiV) and Janssen (771290)UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'The elimination of disease and burden of disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver